NCT01943838View on ClinicalTrials.gov

A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Neoplasm Malignant
Interventions
DRUG

SAR245408

Pharmaceutical form: tablet Route of administration: oral

Trial Locations (1)

3000

Investigational Site Number 056001, Leuven

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01943838 - A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter